Focus
metastatic
LATEST
FDA Approves New Treatment for Metastatic Pancreatic Cancer
The new frontline therapy is the first in a decade intended to treat aggressive pancreatic adenocarcinoma.
|
The new frontline therapy is the first in a decade intended to treat aggressive pancreatic adenocarcinoma.
